Envestnet Asset Management
ADPT icon

Envestnet Asset Management’s Adaptive Biotechnologies ADPT Stock Holding History

Envestnet Asset Management’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
78,503
+16,555
+27% +$254K ﹤0.01% 3283
2026
Q1 		$860K Buy
61,948
+8,332
+16% +$133K ﹤0.01% 3554
2025
Q4 		$871K Sell
53,616
-8,256
-13% -$135K ﹤0.01% 3353
2025
Q3 		$926K Buy
61,872
+21,778
+54% +$265K ﹤0.01% 3369
2025
Q2 		$467K Buy
+40,094
New +$364K ﹤0.01% 3741
2024
Q2 		– Sell
-12,120
Closed -$38.9K – 4164
2024
Q1 		$38.9K Sell
12,120
-6,156
-34% -$23.8K ﹤0.01% 4117
2023
Q4 		$89.6K Sell
18,276
-899
-5% -$4.1K ﹤0.01% 3953
2023
Q3 		$105K Sell
19,175
-4,007
-17% -$26.5K ﹤0.01% 3870
2023
Q2 		$156K Sell
23,182
-1,870
-7% -$13.9K ﹤0.01% 3769
2023
Q1 		$221K Buy
25,052
+2,651
+12% +$23.4K ﹤0.01% 3608
2022
Q4 		$171K Sell
22,401
-2,320
-9% -$18.1K ﹤0.01% 3709
2022
Q3 		$176K Sell
24,721
-1,578
-6% -$14.9K ﹤0.01% 3623
2022
Q2 		$213K Buy
26,299
+7,778
+42% +$68.4K ﹤0.01% 3554
2022
Q1 		$257K Sell
18,521
-27,685
-60% -$435K ﹤0.01% 3535
2021
Q4 		$1.3M Buy
46,206
+985
+2% +$30.2K ﹤0.01% 2451
2021
Q3 		$1.54M Buy
45,221
+164
+0.4% +$5.93K ﹤0.01% 2267
2021
Q2 		$1.84M Buy
45,057
+1,707
+4% +$66.4K ﹤0.01% 2115
2021
Q1 		$1.75M Buy
43,350
+12,972
+43% +$702K ﹤0.01% 2029
2020
Q4 		$1.8M Buy
30,378
+10,145
+50% +$523K ﹤0.01% 1821
2020
Q3 		$984K Buy
20,233
+11,656
+136% +$490K ﹤0.01% 2023
2020
Q2 		$415K Buy
+8,577
New +$313K ﹤0.01% 2515

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Envestnet Asset Management's ADPT Position: Q2 2026 in Review

Envestnet Asset Management increased its Adaptive Biotechnologies (ADPT) stake by 27% in Q2 2026, buying an estimated $254K and bringing the position to 78,503 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #3283.

Envestnet Asset Management first reported a position in ADPT in Q2 2020 and has held it in 21 quarters since. The position peaked at $1.84M in Q2 2021. 300 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Envestnet Asset Management held 78,503 shares of Adaptive Biotechnologies worth $1.68M as of Q2 2026.
  • Envestnet Asset Management bought 16,555 Adaptive Biotechnologies shares in Q2 2026, an estimated $254K.
  • Adaptive Biotechnologies made up ﹤0.01% of Envestnet Asset Management's portfolio in Q2 2026, its #3283 holding.
  • Envestnet Asset Management first reported a position in Adaptive Biotechnologies in Q2 2020 and has held it in 21 quarters since.
  • Envestnet Asset Management's Adaptive Biotechnologies position peaked at $1.84M in Q2 2021.
  • 300 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Envestnet Asset Management's 13F filing for Q2 2026, filed 3 Aug 2026.